title: [Comparative effectiveness of 0.1% metilprednisolone aceponate and 0.05% betamethasone dipropionate among children with nonretractable prepuce].
abstract: OBJECTIVE
  To compare clinical improvement between treatment with metilprednisolone aceponate vs. betamethasone dipropionate among children with nonretractable prepuce.
  
  
  METHODS
  Between August 2001 and November 2002, we carried out a double blind and controlled clinical trial in 34 children with a diagnosis of nonretracable prepuce. Children were randomly assigned to one of the following groups and topical treatment was administered: Group A; metilprednisolone aceponate 0. I 1% and Group B; betamethasone dipropionate 0.05%.
  
  
  RESULTS
  Improvement was noted in 88.2% of our sample studied; (n= 15) children from group A and 76.4% (n= 13) childrenfrom group B; however, we did not observe a significant difference when comparing percentages between the two groups (chi2 = 0.2; p = 0.6).
  
  
  CONCLUSIONS
  The percentage of clinical improvement was similar between the two groups of topical steroid treatment administered.
authors.affiliation: Servicio de Urología, Hospital General de Zona y Medicina Familiar No. 1, IMSS, Colima, Colima, México.
authors.forename: Sergio
authors.initials: S
authors.lastname: Ceballos-González
authors.forename: César
authors.initials: C
authors.lastname: Torres-Cantero
authors.forename: Benjamín
authors.initials: B
authors.lastname: Trujillo-Hernández
authors.forename: Jesús
authors.initials: J
authors.lastname: Muñiz
authors.forename: Miguel
authors.initials: M
authors.lastname: Huerta
authors.forename: Xochitl
authors.initials: X
authors.lastname: Trujillo
authors.forename: Clemente
authors.initials: C
authors.lastname: Vásquez
mesh_terms: D000293:Adolescent; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010409:Penile Diseases / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: D005938:Glucocorticoids; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; C078007:methylprednisolone aceponate; D008775:Methylprednisolone